Elevation Oncology Cash Flow Statement

Financials in millions JOD. Fiscal year is January - December.

Millions JOD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	-0.06	-0.05	-0.01	-0.05	-0.04	-0.04	Upgrade
Loss (Gain) From Sale of Investments	0.03	0.02	-0	0.03	0.01	0.01	Upgrade
Loss (Gain) on Equity Investments	0.01	0.01	-	-	-	-	Upgrade
Other Operating Activities	-	-	-0.01	-	-	-	Upgrade
Change in Accounts Payable	0.03	0.03	0.01	0	0.01	-0.03	Upgrade
Change in Other Net Operating Assets	-0.01	-0.01	0.01	0.01	0.02	-0.02	Upgrade
Levered Free Cash Flow	-0.02	-0.02	0.01	-0.01	-0	-0.08	Upgrade
Unlevered Free Cash Flow	-0.02	-0.02	0.01	-0.01	-0	-0.08	Upgrade
Change in Net Working Capital	-0.02	-0.02	-0.02	-0.02	-0.02	0.05	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.